Who
Olivia Kyusuk Bloom
Director
Company insider
Files Form 4 as: Director, Personalis; EVP, Chief Financial Officer, Geron.
In numbers
- Trades disclosed
- 45
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $1.3M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 20 May 2011
- Last trade
- 12 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 14 May 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 16 May 2025filed 20 May 2025 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 15 Aug 2023filed 21 Sep 2023 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 17 May 2023filed 19 May 2023 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 22 Feb 2023filed 24 Feb 2023 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —575,000 at $0.00 | filing |
| 8 Feb 2023filed 10 Feb 2023 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code M | —400,000 at $0.00 | filing |
| 8 Feb 2023filed 10 Feb 2023 | GERN GeronBiotechnology | SEC FORM 4 Code M | $604K400,000 at $1.51 | filing |
| 8 Feb 2023filed 10 Feb 2023 | GERN GeronBiotechnology | SEC FORM 4 Sold | $1.2M400,000 at $3.08 | filing |
| 17 May 2022filed 19 May 2022 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,035 at $0.00 | filing |
| 17 May 2022filed 19 May 2022 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —10,770 at $0.00 | filing |
| 1 Mar 2022filed 2 Mar 2022 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —10,245 at $0.00 | filing |
| 16 Feb 2022filed 18 Feb 2022 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 1 Mar 2021filed 2 Mar 2022 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,691 at $0.00 | filing |
| 2 Feb 2021filed 4 Feb 2021 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 12 Feb 2020filed 14 Feb 2020 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —291,375 at $0.00 | filing |
| 30 Jan 2019filed 1 Feb 2019 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
News
Financial Comparison: Arvinas (NASDAQ:ARVN) & Geron (NASDAQ:GERN)GERN · tickerreport.com · 20 Oct 2026
0 headlines in the last 90 days name Olivia Kyusuk Bloom; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.